Who Supplies Pomalidomide? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Pomalidomide exports, with 108+ registered manufacturers shipping to buyers across 52+ countries — yet a handful of companies dominate the shipments. MSN LABORATORIES PRIVATE LIMITED holds the largest share at 62.6% (export value: $2.8M). Close behind, NATCO PHARMA LIMITED (21.9%, $967.6K). VISHAKHA IMPEX (1.2%, $51.8K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Pomalidomide? Top Manufacturers & Their Buyers
Flow of Pomalidomide from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Pomalidomide Supplier Network — Key Market Intelligence
The Pomalidomide export market from India is led by MSN LABORATORIES PRIVATE LIMITED, which alone commands a 62.6% share, shipping $2.8M worth of product across 19 shipments. The second-largest exporter, NATCO PHARMA LIMITED, contributes $967.6K (21.9%) to the overall market. Combined, the top two suppliers alone account for 84.5% of all Pomalidomide exports, indicating a relatively concentrated supply base.
Across all 108 tracked manufacturers, the total Pomalidomide export value stands at $4.4M from 662 shipments. The market average shipment value is $6.7K. The single largest buyer relationship in terms of trade value is MSN LABS AMERICAS SASNIT, receiving $1.5M worth of product.
The combined buyer network spans 10 named purchasing companies, including MSN LABS AMERICAS SASNIT, MSN LABS PERU SAC, AIMANT FZC, STR INTERNATIONAL TRADING CO., LTD, XXTERXXFZCX and 5 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1MSN LABORATORIES PRIVATE LIMITED
MSN LABORATORIES PRIVATE LIMITED is the first-largest Pomalidomide exporter from India, with a market share of 62.6% and a total export value of $2.8M across 19 shipments. Their average shipment value of $145.4K is above the market average of $6.7K, suggesting premium or bulk contract pricing.
MSN LABORATORIES PRIVATE LIMITED serves 5 named buyers in our database. MSN LABS AMERICAS SASNIT is the dominant customer, accounting for 54.0% of this supplier's tracked business. Top customers include:
• MSN LABS AMERICAS SASNIT — $1.5M across 10 shipments (54.0% of this supplier's total exports)
• MSN LABS PERU SAC — $454.2K across 3 shipments (16.4% of this supplier's total exports)
• TO THE ORDER MSN LAB — $447.6K across 3 shipments (16.2% of this supplier's total exports)
• MSN LABS AMERICAS SASNIT — $197.5K across 1 shipments (7.1% of this supplier's total exports)
• TO THE ORDER OF — $170.9K across 1 shipments (6.2% of this supplier's total exports)
Key Insight: MSN LABORATORIES PRIVATE LIMITED's per-shipment value of $145.4K is 2081% above the market average of $6.7K, consistent with large-order contracts or value-added formulations.
2NATCO PHARMA LIMITED
NATCO PHARMA LIMITED is the second-largest Pomalidomide exporter from India, with a market share of 21.9% and a total export value of $967.6K across 5 shipments. Their average shipment value of $193.5K is above the market average of $6.7K, suggesting premium or bulk contract pricing.
NATCO PHARMA LIMITED serves 1 named buyer in our database. AIMANT FZC is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• AIMANT FZC — $967.6K across 5 shipments (100.0% of this supplier's total exports)
Key Insight: NATCO PHARMA LIMITED's per-shipment value of $193.5K is 2803% above the market average of $6.7K, consistent with large-order contracts or value-added formulations.
3VISHAKHA IMPEX
VISHAKHA IMPEX is the third-largest Pomalidomide exporter from India, with a market share of 1.2% and a total export value of $51.8K across 25 shipments. Their average shipment value of $2.1K is below the market average of $6.7K, reflecting a high-volume, competitive pricing strategy.
VISHAKHA IMPEX serves 1 named buyer in our database. STR INTERNATIONAL TRADING CO., LTD is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• STR INTERNATIONAL TRADING CO., LTD — $51.8K across 25 shipments (100.0% of this supplier's total exports)
Key Insight: VISHAKHA IMPEX operates with high shipment frequency (25 shipments) at a per-shipment value of $2.1K, indicating a broad distribution network with many smaller, regular orders.
43S PHARMACEUTICALS INDIA PRIVATE LIMITED
3S PHARMACEUTICALS INDIA PRIVATE LIMITED is the fourth-largest Pomalidomide exporter from India, with a market share of 0.7% and a total export value of $32.3K across 14 shipments. Their average shipment value of $2.3K is below the market average of $6.7K, reflecting a high-volume, competitive pricing strategy.
3S PHARMACEUTICALS INDIA PRIVATE LIMITED serves 2 named buyers in our database. XXTERXXFZCX is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• XXTERXXFZCX — $32.3K across 14 shipments (100.0% of this supplier's total exports)
• TO M S MAKIZ PHARMA — $0 across 0 shipments (0.0% of this supplier's total exports)
Key Insight: 3S PHARMACEUTICALS INDIA PRIVATE LIMITED operates with high shipment frequency (14 shipments) at a per-shipment value of $2.3K, indicating a broad distribution network with many smaller, regular orders.
53S CORPORATION
3S CORPORATION is the fifth-largest Pomalidomide exporter from India, with a market share of 0.5% and a total export value of $23.3K across 48 shipments. Their average shipment value of $485 is below the market average of $6.7K, reflecting a high-volume, competitive pricing strategy.
3S CORPORATION serves 4 named buyers in our database. ALQUIMIA LIMITED (COOKST PHARMACY) is the dominant customer, accounting for 65.9% of this supplier's tracked business. Top customers include:
• ALQUIMIA LIMITED (COOKST PHARMACY) — $15.3K across 32 shipments (65.9% of this supplier's total exports)
• ALQUIMIA LIMITED — $3.2K across 7 shipments (13.8% of this supplier's total exports)
• ALQUIMIA LIMITED (COOKST PHARMACY) — $3.1K across 6 shipments (13.5% of this supplier's total exports)
• ALQUIMIA LTD — $1.6K across 3 shipments (6.8% of this supplier's total exports)
Key Insight: 3S CORPORATION operates with high shipment frequency (48 shipments) at a per-shipment value of $485, indicating a broad distribution network with many smaller, regular orders.
6HETERO LABS LIMITED
HETERO LABS LIMITED is the fifth-largest Pomalidomide exporter from India, with a market share of 0.0% and a total export value of $217 across 7 shipments. Their average shipment value of $31 is below the market average of $6.7K, reflecting a high-volume, competitive pricing strategy.
HETERO LABS LIMITED serves 1 named buyer in our database. JUNO PHARMACEUTICALS is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• JUNO PHARMACEUTICALS — $217 across 7 shipments (100.0% of this supplier's total exports)
Key Insight: HETERO LABS LIMITED operates with high shipment frequency (7 shipments) at a per-shipment value of $31, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Pomalidomide Flows
Once Pomalidomide leaves the manufacturing plants of companies like MSN LABORATORIES PRIVATE LIMITED and NATCO PHARMA LIMITED, it travels to 5 destination markets with a combined import value of $4.4M. Colombia absorbs the largest share at 50.5% ($2.2M), followed by United Arab Emirates (25.1%) and Peru (14.9%).
In Colombia — the top destination — named importers include MSN LABS AMERICAS SAS, MSN LABS AMERICAS SASNIT. In United Arab Emirates, key buyers are AIMANT FZC, WORLD HEALTH ORGANIZATION WAREHOUSE.
This geographic spread reflects Pomalidomide's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Pomalidomide Go? Top Importing Countries & Their Buyers
Trade flow of Pomalidomide exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Colombia
Colombia ranks as the first-largest destination for Pomalidomide imports from India, with a total trade value of $2.2M across 5 shipments — representing a 50.5% share of all Pomalidomide exports. The average shipment value of $445.2K is above the global average of $6.7K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Pomalidomide importers in Colombia: MSN LABS AMERICAS SAS is the largest buyer, accounting for 67.0% ($1.5M) of this market's total imports.
• MSN LABS AMERICAS SAS — $1.5M (67.0% of Colombia's total)
• MSN LABS AMERICAS SASNIT — $197.5K (8.9% of Colombia's total)
Key Insight: Colombia's per-shipment average of $445.2K (6580% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Colombia is a key market for Pomalidomide imports from India.
2United Arab Emirates
United Arab Emirates ranks as the second-largest destination for Pomalidomide imports from India, with a total trade value of $1.1M across 4 shipments — representing a 25.1% share of all Pomalidomide exports. The average shipment value of $277.3K is above the global average of $6.7K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Pomalidomide importers in United Arab Emirates: AIMANT FZC is the largest buyer, accounting for 87.2% ($967.6K) of this market's total imports.
• AIMANT FZC — $967.6K (87.2% of United Arab Emirates's total)
• WORLD HEALTH ORGANIZATION WAREHOUSE — $121.0K (10.9% of United Arab Emirates's total)
Key Insight: United Arab Emirates's per-shipment average of $277.3K (4061% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United Arab Emirates is a key market for Pomalidomide imports from India.
3Peru
Peru ranks as the third-largest destination for Pomalidomide imports from India, with a total trade value of $658.9K across 8 shipments — representing a 14.9% share of all Pomalidomide exports. The average shipment value of $82.4K is above the global average of $6.7K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Pomalidomide importers in Peru: MSN LABS PERU SAC is the largest buyer, accounting for 68.9% ($454.2K) of this market's total imports.
• MSN LABS PERU SAC — $454.2K (68.9% of Peru's total)
• DIDRSASR DISTRIBUIDORA DROGUERIA SAGITARIO SRL — $19.0K (2.9% of Peru's total)
Key Insight: Peru's per-shipment average of $82.4K (1136% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Peru is a key market for Pomalidomide imports from India.
4Thailand
Thailand ranks as the fourth-largest destination for Pomalidomide imports from India, with a total trade value of $69.2K across 3 shipments — representing a 1.6% share of all Pomalidomide exports. The average shipment value of $23.1K is above the global average of $6.7K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Pomalidomide importers in Thailand: STR INTERNATIONAL TRADING CO., LTD is the largest buyer, accounting for 96.3% ($66.6K) of this market's total imports.
• STR INTERNATIONAL TRADING CO., LTD — $66.6K (96.3% of Thailand's total)
Key Insight: Thailand's per-shipment average of $23.1K (246% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Thailand is a key market for Pomalidomide imports from India.
5Canada
Canada ranks as the fifth-largest destination for Pomalidomide imports from India, with a total trade value of $64.3K across 4 shipments — representing a 1.5% share of all Pomalidomide exports. The average shipment value of $16.1K is above the global average of $6.7K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Pomalidomide importers in Canada: NATCO PHARMA (CANADA) INC is the largest buyer, accounting for 100.0% ($64.3K) of this market's total imports.
• NATCO PHARMA (CANADA) INC — $64.3K (100.0% of Canada's total)
Key Insight: Canada's per-shipment average of $16.1K (141% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Canada is a key market for Pomalidomide imports from India.
People Also Ask — Pomalidomide Supplier & Trade Network
Who are the top suppliers of Pomalidomide from India?+
Which companies buy Pomalidomide from Indian manufacturers?+
Where does Pomalidomide exported from India go?+
What is the market share of the top Pomalidomide supplier from India?+
What is the average shipment value for Pomalidomide exports from India?+
Is Pomalidomide manufactured in India and exported globally?+
Which country imports the most Pomalidomide from India?+
Who are the buyers of Pomalidomide in United Arab Emirates?+
How concentrated is the Pomalidomide supplier market in India?+
How do I find verified buyers for Pomalidomide in specific countries?+
Pomalidomide Trade Network — Key Takeaways
- 1MSN LABORATORIES PRIVATE LIMITED is India's dominant Pomalidomide exporter with a 62.6% market share and $2.8M in total exports — making it the single most important sourcing entity in this market.
- 2The top 108 suppliers collectively account for 87.0% of all tracked Pomalidomide exports, with a combined trade value of $4.4M.
- 3Colombia is the largest destination market, absorbing 50.5% of India's Pomalidomide exports ($2.2M). United Arab Emirates (25.1%) and Peru (14.9%) follow.
- 4With 662 total shipments averaging $6.7K each, the Pomalidomide export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include MSN LABS AMERICAS SASNIT, MSN LABS PERU SAC, AIMANT FZC, STR INTERNATIONAL TRADING CO., LTD — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 52 countries
Network value: $4.4M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Pomalidomide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Pomalidomide.
- 2.Flow Mapping: 108 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 662 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 52 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
662 Verified Shipments
108 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists